Allison H. Bartlett to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Allison H. Bartlett has written about Immunoglobulins, Intravenous.
Connection Strength
0.234
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.165
-
An unusual cause of appendicitis in a child. Semin Pediatr Infect Dis. 2006 Jul; 17(3):111-2, 177-9.
Score: 0.069